Ertican 40mg Injection
Marketer
Cipla Ltd
Salt Composition
Irinotecan (40mg)
Overview Ertican 40mg Injection
Oncaspar 40mg Injection is indicated for colorectal cancer management. Its mechanism involves inhibiting or retarding cancerous cell proliferation. Administration is via intravenous infusion by a qualified healthcare provider. Dosage frequency and amount are determined by your physician, varying based on your condition and potentially adjusted over time. Strictly adhere to your doctor's prescribed regimen; incorrect usage or overdose can lead to severe adverse reactions. Therapeutic effects may not be apparent for several weeks or months; discontinue only under your doctor's guidance. Common side effects include lassitude, nausea, emesis, debility, and alopecia. This medication can decrease blood cell counts (red and white), increasing infection risk. Report fever, pharyngitis, and persistent diarrhea to your physician immediately. Regular blood tests monitoring blood cell counts, along with cardiac, hepatic, and uric acid levels, are necessary. Prior to initiation, disclose any pre-existing heart, liver, or kidney conditions, or the use of any anti-infective medications. Significant drug interactions are possible; inform your healthcare team of all medications you are currently taking. This injection is contraindicated during gestation and lactation. Employing effective contraception for both partners throughout treatment is crucial to prevent pregnancy.
Uses of Ertican 40mg Injection
Colorectal cancer
Major Benefits of Ertican 40mg Injection:
Administering this medication will be handled by your healthcare provider. Self-medication is strictly prohibited.
Common Side effects of Ertican 40mg Injection:
- Fatigue
- Nausea
- Vomiting
- Weakness
- Hair loss
- Fever
- Anemia (low number of red blood cells)
- Diarrhea
- Decreased white blood cell count (neutrophils)
- Decreased appetite
- Mucosal inflammation
How to use Ertican 40mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
How Ertican 40mg Injection works:
The injectable drug Ertican 40mg is a cancer treatment that inhibits topoisomerase I, a crucial enzyme in cancer cell DNA replication. This inhibition reduces cancerous cell proliferation, leading to their demise.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Alcohol consumption alongside Ertican 40mg Injection may be unsafe; seek medical advice before combining them.
PregnancyCONSULT YOUR DOCTOR
Administering Ertican 40mg Injection during pregnancy poses a confirmed risk to the fetus. Therefore, its use is contraindicated. Exceptions may be made in exceptional, life-threatening circumstances where the potential benefits outweigh the known dangers, at the sole discretion of the prescribing physician. Seek medical advice before use.
Breast feedingUNSAFE
Lactation and the administration of Ertican 40mg Injection are incompatible. Evidence indicates potential infant toxicity from this medication.
DrivingUNSAFE
Administering Ertican 40mg Injection may cause drowsiness, blurred vision, and dizziness, potentially impairing alertness. Driving should be avoided if these effects are experienced.
KidneySAFE IF PRESCRIBED
Ertican 40mg Injection appears to pose minimal risk for individuals with impaired kidney function. Existing evidence indicates dose modification might be unnecessary for this patient group. However, physician consultation is advised. This medication is contraindicated for dialysis patients.
LiverCONSULT YOUR DOCTOR
Insufficient data exists regarding the administration of 40mg Ertican injections to individuals with hepatic impairment. Physician consultation is advised.
What if you forget to take Ertican 40mg Injection :
Omit a dose of Ertican 40mg Injection? Seek your physician's advice.
Facts to Know About Ertican 40mg Injection
| Label | Value |
|---|---|
| Chemical Type | Camptothecin Analog |
| Developing Habits | No. |
| Treatment Category | Cancer Treatments |
| Actions | Topoisomerase inhibitor |
3,018 People bought this recently